MI-192, identified by its CAS number 1415340-63-4, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in treating various diseases. While specific characteristics such as molecular weight, structure, and solubility may vary, MI-192 is generally recognized for its role as a selective inhibitor of certain biological pathways, which may contribute to its therapeutic effects. The compound's mechanism of action often involves modulation of protein interactions or enzymatic activities, making it a candidate for further research in drug development. Additionally, MI-192 may exhibit specific pharmacokinetic properties, influencing its absorption, distribution, metabolism, and excretion in biological systems. As with many investigational compounds, detailed studies are essential to fully understand its efficacy, safety profile, and potential side effects. Researchers continue to explore MI-192's applications, aiming to elucidate its role in clinical settings and its impact on human health.

MI-192

1415340-63-4: MI-192, identified by its CAS number 1415340-63-4, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in treating various diseases. While specific characteristics such as molecular weight, structure, and solubility may vary, MI-192 is generally recognized for its role as a selective inhibitor of certain biological pathways, which may contribute to its therapeutic effects. The compound's mechanism of action often involves modulation of protein interactions or enzymatic activities, making it a candidate for further research in drug development. Additionally, MI-192 may exhibit specific pharmacokinetic properties, influencing its absorption, distribution, metabolism, and excretion in biological systems. As with many investigational compounds, detailed studies are essential to fully understand its efficacy, safety profile, and potential side effects. Researchers continue to explore MI-192's applications, aiming to elucidate its role in clinical settings and its impact on human health.

<p>MI-192 is a synthetic peptide that binds to toll-like receptor 4 (TLR4), inhibiting TNF-α synthesis. It also displays neuroprotective effects in vitro and in vivo, as well as anti-inflammatory activity. MI-192 has been shown to be effective against cancer cells in culture and tumours in mice. A clinical trial for the treatment of glioma is currently underway.</p>

MI 192

<p>MI-192: Selective HDAC2/3 inhibitor, IC50=30/16 nM, induces apoptosis in myeloid leukemia, potential in leukemia/anti-stroke treatment.</p>

CAS 1415340-63-4

MI-192

MI 192

Ref: 3D-QGC34063

MI-192

Ref: TM-T21898